|
End-of-day quote
Other stock markets
|
||
| - LVL | - |
|
| 07/22/07 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 06/22/06 | Notification about results of final buy-back of shares | AQ |
| 30/21/30 | Notification about final share buy-back | AQ |
| 28/21/28 | Correction: Regarding results of a share buy-back offer | AQ |
| 28/21/28 | On substantial participation (4) - specified | AQ |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 01/01/2026 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 01/01/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 19/06/2021 | |
Janis Buks
CHM | Chairman | - | 01/09/2022 |
Roberts Tavjevs
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.16% | +0.85% | +16.23% | +73.77% | 4.94TCr | ||
| +0.40% | +2.57% | +62.13% | +110.97% | 3.63TCr | ||
| +1.85% | +0.17% | -8.72% | +21.84% | 1.19TCr | ||
| -0.54% | -3.48% | +12.57% | +72.26% | 1.15TCr | ||
| -2.43% | 0.00% | +37.53% | +136.73% | 898.9Cr | ||
| -0.92% | +0.98% | +46.25% | -7.14% | 700.4Cr | ||
| +0.95% | -1.59% | +12.78% | +32.81% | 676.17Cr | ||
| -0.27% | -2.32% | +2.13% | +174.18% | 646.21Cr | ||
| +3.51% | -10.69% | -31.55% | +1.09% | 548.53Cr | ||
| Average | +0.33% | -1.06% | +16.59% | +68.50% | 1.6TCr | |
| Weighted average by Cap. | +0.26% | +0.29% | +25.65% | +78.57% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- OLF1R Stock
- OLF1R Stock
Select your edition
All financial news and data tailored to specific country editions
















